Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test in the Surveillance of Patients With Non-Invasive Bladder Urothelial Carcinoma.

NCT04647981 is registered in ClinicalTrials.gov with Clinique Beau Soleil as lead sponsor.

NCT NCT04647981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04647981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test in the Surveillance of Patients With Non-Invasive Bladder Urothelial Carcinoma.
Lead sponsor
Clinique Beau Soleil
Phase
Observational
Overall status
Completed
Start date
May 22, 2019
Completion date
January 2, 2021
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-invasive bladder papillary urothelial carcinoma, high grade, non-invasive bladder papillary urothelial carcinoma, low grade, non-invasive bladder urothelial carcinoma